Canadian Summer Oncology Update

June 23-25, 2017 | Fairmont Chateau Whistler

Welcome to the 6th Canadian Summer Oncology Update (formerly CCOCO) June 23 to 25, 2017. Please join us for this informative and interactive meeting at the beautiful alpine resort of Whistler, BC.

Once again the conference will showcase advances in the different tumor types including GI cancers (colorectal and gastric), breast, lung, renal cell cancers and myeloma.

Our goal of this conference is to bring oncologists, GPOs, residents, nurses, nurse practitioners and pharmacists with an interest in oncology from across Canada together in an environment where challenging cases can be discussed and best practices shared. In each educational segment, there will be a keynote presentation on new and relevant data followed by facilitators who will present a series of interactive case discussions with audience participation. By keeping the program interactive, our hope is to engage the audience to apply new knowledge to specific patient problems.

Another objective is to provide multi-disciplinary strategies in management of tumor types which occurs frequently in the real world of oncology.

We are sure you will appreciate this lively and stimulating educational meeting.  We look forward to welcoming you to Whistler in June 2017.

 Sincerely, your Planning Committee:

Dr. Wendy Lam, BSc. (Pharm), FRCPC
Director BC Community Oncology Trialists, Burnaby Hospital Regional Cancer Centre, Burnaby, BC

Dr. Barbara Melosky, MD, FRCPC
Associate Professor, University of British Columbia, Medical Oncologist, BC Cancer Agency, Vancouver, BC



In accordance with the guidelines governing the organization of CME, the following fees apply:
After May 16, 2017 – Physicians $250, Other Health Care Professionals $125

These fees cover meals for the participant during the conference.
Industry: Non sponsoring industry please contact Island Events Inc. (INDUSTRY is defined by 360inc. Planning Solutions as any person employed by a for-profit organization, including, biotech, financial, and pharmaceutical.)